Progenics, Wyeth drug fails late-stage trial
This is a discussion on Progenics, Wyeth drug fails late-stage trial within the Biotechnology News forum, part of the Industry News and Updates category; There's more bad news for Wyeth and Progenics Pharmaceuticals for their late-stage drug Relistor. Researchers say the drug ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
05-22-2008, 03:06 PM
|
|||
|
|||
Progenics, Wyeth drug fails late-stage trial
There's more bad news for Wyeth and Progenics Pharmaceuticals for their late-stage drug Relistor. Researchers say the drug failed to hit a primary endpoint in restoring gastrointestinal function Read more...
More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Rituxan fails (again) in late-stage lupus trial | industry_news | Biotechnology News | 0 | 04-29-2008 04:27 PM |
| FDA approves Wyeth, Progenics drug | industry_news | Biotechnology News | 0 | 04-25-2008 11:59 PM |
| Boehringer boasts of late-stage drug potential | industry_news | Biotechnology News | 0 | 04-08-2008 02:55 PM |
| Wyeth, Progenics drug flunks Phase III trial | industry_news | Biotechnology News | 0 | 03-19-2008 09:08 AM |
| Wyeth, Progenics drug flunks trial | industry_news | Biotechnology News | 0 | 03-12-2008 01:40 PM |
© 2008 DrugManagementForum™ powered by |
 |